These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
596 related articles for article (PubMed ID: 32583288)
1. CHA2DS2-VASc and ATRIA Scores and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction. Zhu W; Wu Y; Zhou Y; Liang W; Xue R; Wu Z; Dong Y; Liu C Cardiovasc Drugs Ther; 2020 Dec; 34(6):763-772. PubMed ID: 32583288 [TBL] [Abstract][Full Text] [Related]
2. Predicting stroke and death in patients with heart failure using CHA Son MK; Lim NK; Park HY BMC Cardiovasc Disord; 2019 Aug; 19(1):193. PubMed ID: 31395009 [TBL] [Abstract][Full Text] [Related]
3. Usefulness of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients. Wu Y; Xie Z; Liang W; Xue R; Wu Z; Wu D; He J; Zhu W; Liu C ESC Heart Fail; 2021 Apr; 8(2):1369-1377. PubMed ID: 33506643 [TBL] [Abstract][Full Text] [Related]
4. Essen Stroke Risk Score Predicts Clinical Outcomes in Heart Failure Patients with Preserved Ejection Fraction: Evidence from the TOPCAT trial. Zhu W; Cao Y; Ye M; Huang H; Wu Y; Ma J; Dong Y; Liu X; Liu C; Lip GYH Thromb Haemost; 2023 Jan; 123(1):85-96. PubMed ID: 36037830 [TBL] [Abstract][Full Text] [Related]
5. Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction. Sandesara PB; Hammadah M; Samman-Tahhan A; Kelli HM; O'Neal WT Clin Cardiol; 2017 Sep; 40(9):692-696. PubMed ID: 28444995 [TBL] [Abstract][Full Text] [Related]
6. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation. Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604 [TBL] [Abstract][Full Text] [Related]
7. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation. Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809 [TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis. Kroshian G; Joseph J; Kinlay S; Peralta AO; Hoffmeister PS; Singh JP; Yuyun MF J Cardiovasc Electrophysiol; 2024 Apr; 35(4):715-726. PubMed ID: 38348517 [TBL] [Abstract][Full Text] [Related]
9. CHA2DS2-VASc score performance to predict stroke after acute decompensated heart failure with and without reduced ejection fraction. Berkovitch A; Mazin I; Younis A; Shlomo N; Nof E; Goldenberg I; Beinart R Europace; 2019 Nov; 21(11):1639-1645. PubMed ID: 31390461 [TBL] [Abstract][Full Text] [Related]
10. Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial. Lewis EF; Claggett B; Shah AM; Liu J; Shah SJ; Anand I; O'Meara E; Sweitzer NK; Rouleau JL; Fang JC; Desai AS; Retta TM; Solomon SD; Heitner JF; Stamos TD; Boineau R; Pitt B; Pfeffer MA Circ Heart Fail; 2018 Mar; 11(3):e004457. PubMed ID: 29664406 [TBL] [Abstract][Full Text] [Related]
11. C Liang W; Wu Y; Xue R; Wu Z; Wu D; He J; Dong Y; Lip GYH; Zhu W; Liu C BMC Med; 2021 Feb; 19(1):44. PubMed ID: 33596909 [TBL] [Abstract][Full Text] [Related]
12. Both HFpEF and HFmrEF should be included in calculating CHA Cheng CC; Huang PS; Chen JJ; Chiu FC; Chang SN; Wang YC; Wu CK; Hwang JJ; Tsai CT Heart Rhythm; 2024 Sep; 21(9):1500-1506. PubMed ID: 38423377 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction. Santos AB; Roca GQ; Claggett B; Sweitzer NK; Shah SJ; Anand IS; Fang JC; Zile MR; Pitt B; Solomon SD; Shah AM Circ Heart Fail; 2016 Apr; 9(4):e002763. PubMed ID: 27056882 [TBL] [Abstract][Full Text] [Related]
14. Diastolic Blood Pressure and Adverse Outcomes in the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) Trial. Sandesara PB; O'Neal WT; Kelli HM; Topel M; Samman-Tahhan A; Sperling LS J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475874 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of CHA2DS2-VASc score in predicting high SYNTAX score and in-hospital mortality for non-ST elevation myocardial infarction in patients without atrial fibrillation. Akboğa MK; Yılmaz S; Yalçın R Anatol J Cardiol; 2021 Nov; 25(11):789-795. PubMed ID: 34734812 [TBL] [Abstract][Full Text] [Related]
16. Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant). Gažová A; Leddy JJ; Rexová M; Hlivák P; Hatala R; Kyselovič J Medicine (Baltimore); 2019 Aug; 98(31):e16560. PubMed ID: 31374021 [TBL] [Abstract][Full Text] [Related]
17. Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial. Anand IS; Claggett B; Liu J; Shah AM; Rector TS; Shah SJ; Desai AS; O'Meara E; Fleg JL; Pfeffer MA; Pitt B; Solomon SD JACC Heart Fail; 2017 Apr; 5(4):241-252. PubMed ID: 28359411 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Minimal Left Atrial Volume in Heart Failure With Preserved Ejection Fraction. Shin SH; Claggett B; Inciardi RM; Santos ABS; Shah SJ; Zile MR; Pfeffer MA; Shah AM; Solomon SD J Am Heart Assoc; 2021 Aug; 10(15):e019545. PubMed ID: 34325519 [TBL] [Abstract][Full Text] [Related]
19. Stroke risk scores to predict hospitalization for acute decompensated heart failure in atrial fibrillation patients. Ivănescu AC; Dan GA Rom J Intern Med; 2021 Mar; 59(1):73-82. PubMed ID: 33125341 [No Abstract] [Full Text] [Related]